{
  "_id": "6802918d3ccffd1c7912ca2f",
  "ipo_id": "2021_tatva_chintan_pharma_chem_ltd_ipo",
  "__v": 0,
  "_metadata": {
    "sectionsAvailable": {
      "basicDetails": true,
      "tentativeSchedule": true,
      "lotSize": true,
      "timeline": false,
      "kpi": false,
      "financials": true,
      "promoterHolding": true,
      "objectives": false,
      "about": true,
      "subscriptionStatus": true,
      "contactDetails": true,
      "registrarDetails": true,
      "leadManagers": true,
      "listingDetails": true,
      "listingDayTrading": true,
      "faqs": true,
      "recommendationSummary": true,
      "prospectusLinks": true,
      "reservation": true,
      "anchorInvestors": false
    },
    "scrapedAt": "2025-04-18T17:47:21.211Z",
    "sourceUrl": "https://www.chittorgarh.com/ipo/tatva-chintan-pharma-ipo/1127/"
  },
  "about": {
    "details": "<p>Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs),&nbsp;pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.</p>\n\n<p>The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.</p>\n\n<p>Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.</p>\n\n<p><strong>Competitive strengths</strong></p>\n<ul>\n<li>Leading manufacturer of structure directing agents and phase transfer catalyst.</li>\n<li>Diversified product portfolio.</li>\n<li>Global market presence with customer base across industries.</li>\n<li>Strategically located manufacturing facility in Gujarat with close proximity to&nbsp;Hazira Port.</li>\n<li>Experienced promoters and managers team.</li>\n<li>Strong financial performance track record.</li>\n</ul>"
  },
  "additionalTables": [
    {
      "heading": "Company Financials",
      "sanitizedHeading": "financials",
      "headers": [
        "Particulars",
        "For the year/period ended ( in million)"
      ],
      "rows": [
        [
          null,
          "31-Mar-21",
          "31-Mar-20",
          "31-Mar-19"
        ],
        [
          "Total Assets",
          "3148.03",
          "2489.38",
          "1875.08"
        ],
        [
          "Total Revenue",
          "3062.92",
          "2646.22",
          "2068.01"
        ],
        [
          "Profit After Tax",
          "522.62",
          "377.89",
          "205.43"
        ]
      ]
    }
  ],
  "basicDetails": {
    "ipoDate": "July 16, 2021 to July 20, 2021",
    "ipoListingDate": "Thu, Jul 29, 2021",
    "faceValue": "₹10 per share",
    "issuePrice": "₹1,083.00",
    "lotSize": "13 Shares",
    "issueSize": "[.] shares (aggregating up to ₹500.00 Cr)",
    "freshIssue": "[.] shares (aggregating up to ₹225.00 Cr)",
    "offerForSale": "[.] shares of ₹10 (aggregating up to ₹275.00 Cr)",
    "issueType": "Bookbuilding IPO",
    "listingAt": "BSE, NSE",
    "ipoOpenDate": "Fri, Jul 16, 2021",
    "ipoCloseDate": "Tue, Jul 20, 2021",
    "initiationOfRefunds": "Tue, Jul 27, 2021",
    "creditOfSharesToDemat": "Wed, Jul 28, 2021",
    "shareHoldingPreIssue": "2,00,87,500 shares",
    "shareHoldingPreIssueAll": [
      {
        "label": "Share Holding Pre Issue",
        "value": "2,00,87,500 shares"
      },
      {
        "label": "Share Holding Pre Issue",
        "value": "100%"
      }
    ],
    "shareHoldingPostIssue": "2,21,65,062 shares",
    "shareHoldingPostIssueAll": [
      {
        "label": "Share Holding Post Issue",
        "value": "2,21,65,062 shares"
      },
      {
        "label": "Share Holding Post Issue",
        "value": "79.17%"
      }
    ]
  },
  "closing_date": "2021-07-19T18:30:00.000Z",
  "contactDetails": {
    "phone": "+91 75730 46951",
    "email": "cs@tatvachintan.com",
    "full_address": "Tatva Chintan Pharma Chem Ltd, Plot No. 502 / 17 GIDC Estate Ankleshwar, Bharuch Gujarat - 393002 India",
    "website": "http://www.tatvachintan.com/"
  },
  "createdAt": "2025-04-18T17:53:17.030Z",
  "faqs": [
    {
      "question": "What is the Tatva Chintan Pharma IPO?",
      "answer": "<div itemprop=\"text\"><p>Tatva Chintan Pharma IPO<!-- --> is a <b>main-board<!-- --> <!-- -->IPO<!-- --> of <!-- --> equity shares</b> of the face value of ₹<!-- -->10<!-- --> aggregating up to ₹<!-- -->500.00<!-- --> Crores. The issue is priced at <span>₹1083 per share</span>. The minimum order quantity is <!-- -->13<!-- -->.</p><p>The <!-- -->IPO<!-- --> <b>opens on <!-- -->July 16, 2021</b>, and <b>closes on <!-- -->July 20, 2021</b>.</p><p>Link Intime India Private Ltd<!-- --> is the registrar for the <!-- -->IPO<!-- -->. The shares are proposed to be listed on <!-- -->BSE, NSE<!-- -->.</p></div>"
    },
    {
      "question": "How to apply in Tatva Chintan Pharma IPO through Zerodha?",
      "answer": "<div itemprop=\"text\"><p>Zerodha customers can apply online in <!-- -->Tatva Chintan Pharma IPO<!-- --> using UPI as a payment gateway. Zerodha customers can apply in <!-- -->Tatva Chintan Pharma IPO<!-- --> by login into Zerodha Console (back office) and submitting an IPO application form.</p><p><strong>Steps to apply in <!-- -->Tatva Chintan Pharma IPO<!-- --> through Zerodha</strong></p><ol><li>Visit the Zerodha website and login to Console.</li><li>Go to Portfolio and click the IPOs link.</li><li>Go to the '<!-- -->Tatva Chintan Pharma IPO<!-- -->' row and click the 'Bid' button.</li><li>Enter your UPI ID, Quantity, and Price.</li><li>Submit IPO application form.</li><li>Visit the UPI App (net banking or BHIM) to approve the mandate.</li></ol><p>Visit <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Application Process Review\">Zerodha IPO Application Process Review</a> for more detail.</p></div>"
    },
    {
      "question": "When Tatva Chintan Pharma IPO will open?",
      "answer": "<div itemprop=\"text\"><p>The Tatva Chintan Pharma IPO opens on July 16, 2021 and closes on July 20, 2021.</p></div>"
    },
    {
      "question": "What is the lot size of Tatva Chintan Pharma IPO?",
      "answer": "<div itemprop=\"text\"><p>Tatva Chintan Pharma IPO<!-- --> <b>lot size is <!-- -->13</b>, and the <b>minimum amount required is <span>₹14,079</span></b>.</p></div>"
    },
    {
      "question": "How to apply for Tatva Chintan Pharma IPO?",
      "answer": "<div itemprop=\"text\"><p>You can apply in <!-- -->Tatva Chintan Pharma IPO<!-- --> online using either <a href=\"/article/upi-payment-option-ipo-application-explained/382/\">UPI</a> or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Review\"><b>Zerodha</b></a>, <a href=\"/broker/upstox/ipo/33/\" title=\"Upstox IPO Review\">Upstox</a>, <a href=\"/broker/5paisa/ipo/4/\" title=\"5Paisa IPO Review\">5Paisa</a>, <a href=\"/broker/edelweiss_broking/ipo/34/\" title=\"Nuvama IPO Review\">Nuvama</a>, <a href=\"/broker/hdfc-securities/ipo/6/\" title=\"HDFC Bank IPO Review\">HDFC Bank</a>, and <a href=\"/broker/sbi-capital/ipo/19/\" title=\"SBI Capital IPO Review\">SBI Bank</a>.</p></div>"
    },
    {
      "question": "When is Tatva Chintan Pharma IPO allotment?",
      "answer": "<div itemprop=\"text\"><p>The finalization of Basis of Allotment for <!-- -->Tatva Chintan Pharma IPO<!-- --> will be done on <!-- -->Monday, July 26, 2021<!-- -->, and the allotted shares will be credited to your demat account by <!-- -->Wednesday, July 28, 2021<!-- -->. Check the <a href=\"/ipo_allotment_status/tatva-chintan-pharma-ipo/1127/\" title=\"Tatva Chintan Pharma IPO Allotment Status\">Tatva Chintan Pharma IPO<!-- --> allotment status</a>.</p></div>"
    },
    {
      "question": "When is Tatva Chintan Pharma IPO listing date?",
      "answer": "<div itemprop=\"text\"><p>The <!-- -->Tatva Chintan Pharma IPO<!-- --> listing date is on <b>Thursday, July 29, 2021</b>.</p></div>"
    }
  ],
  "ipoName": "Tatva Chintan Pharma Chem",
  "issue_price": "₹1,083.00",
  "issue_price_numeric": 1,
  "issue_size": "[.] shares (aggregating up to ₹500.00 Cr)",
  "issue_size_numeric": 500,
  "leadManagerReports": [
    {
      "text": "IPO Lead Manager Performance Summary",
      "url": "/report/ipo_lead_manager_performance_tracker/19/"
    },
    {
      "text": "IPO Lead Manager Performance Tracker",
      "url": "/report/ipo-lead-manager-vs-listing-gain/99/17/"
    }
  ],
  "leadManagers": [
    {
      "name": "ICICI Securities Limited",
      "url": "/report/ipo-lead-manager-review/112/17/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/17/"
    },
    {
      "name": "Jm Financial Limited",
      "url": "/report/ipo-lead-manager-review/112/18/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/18/"
    }
  ],
  "listingDayTrading": {
    "data": {
      "final_issue_price": {
        "bse": "1083.00",
        "nse": "1083.00"
      },
      "open": {
        "bse": "2111.80",
        "nse": "2111.85"
      },
      "low": {
        "bse": "2111.80",
        "nse": "2111.85"
      },
      "high": {
        "bse": "2486.30",
        "nse": "2534.20"
      },
      "last_trade": {
        "bse": "2310.25",
        "nse": "2312.20"
      }
    },
    "performance_link": {
      "text": "Check IPO Performance…",
      "url": "/ipo/ipo_perf_tracker.asp"
    }
  },
  "listingDetails": {
    "pre_open_links": [
      {
        "text": "Pre-Open Session - NSE",
        "url": "https://www.nseindia.com/market-data/new-stock-exchange-listings-today"
      },
      {
        "text": "Pre-Open Session - BSE",
        "url": "https://www.bseindia.com/eqstreamer/StockTickerSplPreOpen.html"
      }
    ],
    "ipo_date": "July 29 2021",
    "bse_script_code": "543321",
    "nse_symbol": "TATVA",
    "isin": "INE0GK401011",
    "final_issue_price": "1083 per share"
  },
  "listing_date": "2021-07-28T18:30:00.000Z",
  "listing_gains": "113.32%",
  "listing_gains_numeric": 113.32,
  "logo": "https://www.chittorgarh.net/images/ipo/tatva-chintan-pharma-chem-logo.png",
  "logo_url": "https://www.chittorgarh.net/images/ipo/tatva-chintan-pharma-chem-logo.png",
  "lotSize": {
    "summary": "Investors can bid for a minimum of 13 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.",
    "applications": {
      "retail_min": {
        "application": "Retail (Min)",
        "lots": "1",
        "shares": "13",
        "amount": "14079"
      },
      "retail_max": {
        "application": "Retail (Max)",
        "lots": "14",
        "shares": "182",
        "amount": "197106"
      },
      "shni_min": {
        "application": "S-HNI (Min)",
        "lots": "15",
        "shares": "195",
        "amount": "211185"
      },
      "shni_max": {
        "application": "S-HNI (Max)",
        "lots": "71",
        "shares": "923",
        "amount": "999609"
      },
      "bhni_min": {
        "application": "B-HNI (Min)",
        "lots": "72",
        "shares": "936",
        "amount": "1013688"
      },
      "lot_size": {
        "application": "Lot Size Calculator"
      }
    },
    "calculator_link": {
      "text": "Lot Size Calculator",
      "url": "/ipo-hni-funding-cost-calculator/tatva-chintan-pharma-ipo/1127/"
    }
  },
  "lot_size": 13,
  "opening_date": "2021-07-15T18:30:00.000Z",
  "pageHeading": "Tatva Chintan Pharma Chem Ltd IPO (Tatva Chintan Pharma IPO) Detail",
  "pageTitle": "Tatva Chintan Pharma IPO Date, Price, GMP, Review, Details",
  "promoterHolding": {
    "promoters": "Ajaykumar Mansukhlal Patel Chintan Nitinkumar Shah and Snehkar Rasiklal Somani are the company promoters.",
    "holdings": {
      "share_holding_pre_issue": "100%",
      "share_holding_post_issue": "79.17%"
    },
    "note": "The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue"
  },
  "prospectusLinks": [
    {
      "text": "Tatva Chintan Pharma IPO DRHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/apr-2021/tatva-chintan-pharma-drhp_49757.html"
    },
    {
      "text": "Tatva Chintan Pharma IPO RHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/jul-2021/tatva-chintan-pharma-chem-limited_51381.html"
    }
  ],
  "recommendationSummary": {
    "recommendations": {
      "brokersbrokers": {
        "subscribe": "8",
        "neutral": "2",
        "avoid": "0"
      },
      "membersmembers": {
        "subscribe": "0",
        "neutral": "0",
        "avoid": "0"
      }
    },
    "links": [
      {
        "text": "Read All Reviews",
        "url": "/ipo-recommendation/tatva-chintan-pharma-ipo/1127/"
      },
      {
        "text": "Post Your Review",
        "url": "#"
      },
      {
        "text": "Manage Reviews",
        "url": "#"
      }
    ]
  },
  "registrarDetails": {
    "name": "Link Intime India Private Ltd",
    "phone": "+91-22-4918 6270",
    "email": "tatva.ipo@linkintime.co.in",
    "website": "https://linkintime.co.in/Initial_Offer/public-issues.html"
  },
  "reservation": {
    "summary": "Tatva Chintan Pharma IPO offers 3261882 shares. 931966 (28.57%) to QIB 698975 (21.43%) to NII 1630941 (50.00%) to RII. 125457 RIIs will receive minimum 13 shares and (sNII) and (bNII) will receive minimum 195 shares. (in case of oversubscription)",
    "allocation": [
      {
        "investor_category": "Anchor Investor Shares Offered",
        "shares_offered": "-",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "QIB Shares Offered",
        "shares_offered": "931966 (28.57%)",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "NII (HNI) Shares Offered",
        "shares_offered": "698975 (21.43%)"
      },
      {
        "investor_category": "Retail Shares Offered",
        "shares_offered": "1630941 (50.00%)",
        "maximum_allottees": "125457"
      },
      {
        "investor_category": "Total Shares Offered",
        "shares_offered": "3261882 (100%)"
      }
    ]
  },
  "scraped_at": "2025-04-18T17:53:17.030Z",
  "source_url": "",
  "status": "listed",
  "subscriptionStatus": {
    "summary": "The Tatva Chintan Pharma IPO is subscribed 180.36 times on July 20 2021 5:01:00 PM (Day 3). The public issue subscribed 35.35 times in the retail category 185.23 times in the QIB category and 512.22 times in the NII category. Check Day by Day Subscription Details (Live Status)",
    "overall": {
      "qib": {
        "category": "QIB",
        "subscription_times": "185.23",
        "shares_offered": "931966",
        "shares_bid_for": "172628313"
      },
      "nii": {
        "category": "NII",
        "subscription_times": "512.22",
        "shares_offered": "698975",
        "shares_bid_for": "358028073"
      },
      "retail": {
        "category": "Retail",
        "subscription_times": "35.35",
        "shares_offered": "1630941",
        "shares_bid_for": "57652010"
      },
      "total": {
        "category": "Total",
        "subscription_times": "180.36",
        "shares_offered": "3261882",
        "shares_bid_for": "588308396"
      }
    }
  },
  "tentativeDetails": {
    "ipo_date": "5 PM on July 20 2021",
    "tentative_allotment": "Mon Jul 26 2021",
    "initiation_of_refunds": "Tue Jul 27 2021",
    "credit_of_shares_to_demat": "Wed Jul 28 2021"
  },
  "updatedAt": "2025-04-19T04:38:18.810Z",
  "updated_at": "2025-04-18T17:53:17.030Z",
  "year": 2021,
  "worst_listing_gains": "113.32%",
  "worst_listing_gains_numeric": 113.32
}